The airway epithelial cell is an important target in ozone injury. Onc
e activated, the airway epithelium responds in three phases. The initi
al, or immediate phase, involves activation of constitutive cells, oft
en through direct covalent interactions including the formation of sec
ondary ozonolysis products-hydroxyhydroperoxides, aldehydes, and hydro
gen peroxide. Recently, we found hydroxyhydroperoxides to be potent ag
onists of bioactive eicosanoid formation by human airway epithelial ce
lls in culture. Other probable immediate events include activation and
inactivation of enzymes present on the epithelial surface (e.g., neut
ral endopeptidase). During the next 2 to 24 hr, or early phase, epithe
lial cells respond by synthesis and release of chemotactic factors, in
cluding chemokines-macrophage inflammatory protein-2, RANTES, and inte
rleukin-8. Infiltrating leukocytes during this period also release ela
stase, an important agonist of epithelial cell mucus secretion and add
itional chemokine formation. The third (late) phase of ozone injury is
characterized by eosinophil or monocyte infiltration. Cytokine expres
sion leads to alteration of structural protein synthesis, with increas
es in fibronectin evident by in situ hybridization. Synthesis of epith
elial antiproteases, e.g., secretory leukocyte protease inhibitor, may
also increase locally 24 to 48 hr after eiastase concentrations becom
e excessive. Thus, the epithelium is not merely a passive barrier to o
zone injury but has a dynamic role in directing the migration, activat
ing, and then counteracting inflammatory cells. Through these complex
interactions, epithelial cells can be viewed as the initiators (alpha)
and the receptors (omega) of ozone-induced airway disease.